{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T08:58:03Z","timestamp":1649062683460},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mod Rheumatol"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s10165-009-0226-5","type":"journal-article","created":{"date-parts":[[2009,9,24]],"date-time":"2009-09-24T11:15:48Z","timestamp":1253790948000},"page":"18-23","source":"Crossref","is-referenced-by-count":3,"title":["Usefulness and limitations of QuantiFERON-TB Gold in Japanese rheumatoid arthritis patients: proposal to decrease the lower cutoff level for assessing latent tuberculosis infection"],"prefix":"10.1093","volume":"20","author":[{"given":"Tomoyo","family":"Maeda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Banno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taio","family":"Naniwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihito","family":"Hayami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rei","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuzo","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,9,25]]},"reference":[{"key":"226_CR1","first-page":"1436","volume":"300","author":"L Carmona","year":"2003","unstructured":"Carmona L, Hernandez-Garcia C, Vadillo C, Pato E, Balsa A, Gonzalez-Alvaro I, et al. Increased risk of tuberculosis in patients with rheumatoid arthritis. J Rheumatol. 2003;300:1436\u20139.","journal-title":"J Rheumatol"},{"key":"226_CR2","first-page":"706","volume":"34","author":"SS Seong","year":"2007","unstructured":"Seong SS, Choi CB, Woo JH, Bae KW, Joung CL, Uhm WS, et al. Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers. J Rheumatol. 2007;34:706\u201311.","journal-title":"J Rheumatol"},{"key":"226_CR3","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1002\/art.21137","volume":"52","author":"J Askling","year":"2005","unstructured":"Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Coster L, et al. Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden. Arthritis Rheum. 2005;52:1986\u201392.","journal-title":"Arthritis Rheum"},{"key":"226_CR4","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1002\/art.21382","volume":"52","author":"KL Winthrop","year":"2005","unstructured":"Winthrop KL, Siegel JN, Jereb J, Taylor Z, Iademarco MF, et al. Tuberculosis associated with therapy against tumor necrosis factor \u03b1. Arthritis Rheum. 2005;52:2968\u201374.","journal-title":"Arthritis Rheum"},{"key":"226_CR5","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","volume":"345","author":"J Keane","year":"2001","unstructured":"Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med. 2001;345:1098\u2013104.","journal-title":"N Engl J Med"},{"key":"226_CR6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1473-3099(03)00545-0","volume":"3","author":"MA Gardam","year":"2003","unstructured":"Gardam MA, Keystone EC, Menzies R, Manners S, Skamene E, Long R, et al. Anti-tumor necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis. 2003;3:148\u201355.","journal-title":"Lancet Infect Dis"},{"key":"226_CR7","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.21043","volume":"52","author":"L Carmona","year":"2005","unstructured":"Carmona L, G\u00f3mez-Reino JJ, Rodr\u00edguez-Valverde V, Montero D, Pascual-G\u00f3mez E, Mola EM, et al. Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum. 2005;52:1766\u201372.","journal-title":"Arthritis Rheum"},{"key":"226_CR8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/ard.2007.072967","volume":"67","author":"T Takeuchi","year":"2008","unstructured":"Takeuchi T, Tatsuki Y, Nogami Y, Ishiguro N, Tanaka Y, Yamanaka H, et al. Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis. Ann Rheum Dis. 2008;67:189\u201394.","journal-title":"Ann Rheum Dis"},{"key":"226_CR9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/s10165-007-0626-3","volume":"17","author":"R Koike","year":"2007","unstructured":"Koike R, Takeuchi T, Eguchi K, Miyasaka N, Japan College of Rheumatology. Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis. Mod Rheumatol. 2007;17:451\u20138.","journal-title":"Mod Rheumatol"},{"key":"226_CR10","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3899\/jrheum.080791","volume":"36","author":"T Koike","year":"2009","unstructured":"Koike T, Harigai M, Inokuma S, Inoue K, Ishiguro N, Ryu J, et al. Postmarketing surveillance of the safety and effectiveness of etanercept in Japan. J Rheumatol. 2009;36:898\u2013906.","journal-title":"J Rheumatol"},{"key":"226_CR11","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-149-10-200811180-00003","volume":"149","author":"D Menzies","year":"2008","unstructured":"Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, et al. Adverse events with4\u00a0months of rifampin therapy or 9\u00a0months of isoniazid therapy for latent tuberculosis infection: a randomized trial. Ann Intern Med. 2008;149:689\u201397.","journal-title":"Ann Intern Med"},{"key":"226_CR12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","volume":"149","author":"M Pai","year":"2008","unstructured":"Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008;149:177\u201384.","journal-title":"Ann Intern Med"},{"key":"226_CR13","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1378\/chest.07-1995","volume":"133","author":"Y Kobashi","year":"2008","unstructured":"Kobashi Y, Mouri K, Yagi S, Obase Y, Miyashita N, Okimoto N, et al. Clinical utility of the QuantiFERON TB-2G test for elderly patients with active tuberculosis. Chest. 2008;133:1196\u2013202.","journal-title":"Chest"},{"key":"226_CR14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200402-179OC","volume":"170","author":"T Mori","year":"2004","unstructured":"Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med. 2004;170:59\u201364.","journal-title":"Am J Respir Crit Care Med"},{"key":"226_CR15","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1128\/JCM.39.10.3603-3608.2001","volume":"39","author":"R Maekura","year":"2001","unstructured":"Maekura R, Okuda Y, Nakagawa M, Hiraga T, Yokota S, Ito M, et al. Clinical evaluation of anti-tuberculous glycolipid immunoglobulin G antibody assay for rapid serodiagnosis of pulmonary tuberculosis. J Clin Microbiol. 2001;39:3603\u20138.","journal-title":"J Clin Microbiol"},{"key":"226_CR16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/(SICI)1098-2825(1997)11:3<140::AID-JCLA4>3.0.CO;2-E","volume":"11","author":"M Kawamura","year":"1997","unstructured":"Kawamura M, Sueshige N, Imayoshi K, Yano I, Maekura R, Kohno H. Enzyme immunoassay to detect antituberculous glycolipid antigen (anti-TBGL antigen) antibodies in serum for diagnosis of tuberculosis. J Clin Lab Anal. 1997;11:140\u20135.","journal-title":"J Clin Lab Anal"},{"key":"226_CR17","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/ard.2004.029041","volume":"64","author":"D Ponce de Leon","year":"2005","unstructured":"Ponce de Leon D, Acevedo-Vasquez E, Sanchez-Torres A, Cucho M, Alfaro J, Perich R, et al. Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in population with a high prevalence of tuberculosis. Ann Rheum Dis. 2005;64:1360\u20131.","journal-title":"Ann Rheum Dis"},{"key":"226_CR18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/ard.2006.061184","volume":"66","author":"P Efthimiou","year":"2007","unstructured":"Efthimiou P, Sood S. QuantiFERON TB Gold Test: the new standard for screening of latent tuberculosis in patients with rheumatoid arthritis? Ann Rheum Dis. 2007;66:276.","journal-title":"Ann Rheum Dis"},{"key":"226_CR19","first-page":"776","volume":"3","author":"D Ponce de Leon","year":"2008","unstructured":"Ponce de Leon D, Acevedo-Vasquez E, Alvizuri S, Gutierrez C, Cucho M, Alfaro J, et al. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. J Rheumatol. 2008;3:776\u201381.","journal-title":"J Rheumatol"},{"key":"226_CR20","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/rheumatology\/kem064","volume":"46","author":"A Pratt","year":"2007","unstructured":"Pratt A, Nicholl K, Kay L. Use of the QuantiFERON TB Gold test as part of a screening programme in patients with RA under consideration for treatment with anti-TNF-alpha agents: the Newcastle (UK) experience. Rheumatology (Oxford). 2007;46:1035\u20136.","journal-title":"Rheumatology (Oxford)"},{"key":"226_CR21","doi-asserted-by":"crossref","unstructured":"Wu-Hsieh BA, Chen CK, Chang JH, Lai SY, Wu CH, Cheng WC, et al. Long-lived immune response to early secretory antigenic target 6 in individuals who had recovered from tuberculosis. Clin Infect Dis 2001;33:1336\u201340.","DOI":"10.1086\/323044"},{"key":"226_CR22","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.2169\/internalmedicine.47.1313","volume":"47","author":"Y Kobashi","year":"2008","unstructured":"Kobashi Y, Sugiu T, Ohue Y, Mouri K, Obase Y, Miyashita N, et al. Long-term follow-up of the QuantiFERON TB-2G test for active tuberculosis disease. Intern Med. 2008;47:1957\u201361.","journal-title":"Intern Med"},{"key":"226_CR23","first-page":"123","volume":"57","author":"P Emery","year":"1984","unstructured":"Emery P, Panayi GS, Nouri AM. Interleukin-2 reverses deficient cell-mediated immune responses in rheumatoid arthritis. Clin Exp Immunol. 1984;57:123\u20139.","journal-title":"Clin Exp Immunol"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10165-009-0226-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:25:13Z","timestamp":1646843113000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10165-009-0226-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,25]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["226"],"URL":"https:\/\/doi.org\/10.1007\/s10165-009-0226-5","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,25]]}}}